WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

RED CELL DISTRIBUTION WIDTH: A USEFUL MARKER OF DISEASE ACTIVITY IN INFLAMMATORY BOWEL DISEASE

Yassir Sabeeh, Dr. Malallah Akreem Ammer* and Laith Hikmetmihsun

ABSTRACT

Background and Objective: Studies concerning red cell distribution width (RDW) for use in the assessment of inflammatory bowel disease (IBD) activity are limited. We investigated whether RDW is a useful clinical marker of active disease in patients with IBD. Methods: In total, (66) patients with ulcerative colitis (UC) and (28) patients with Crohn’s disease (CD) were enrolled in the study group, and (40) age- and-sex-matched healthy sub-jects were included as the control group. A CD activity index >150 was considered to indi-cate active disease, while moderate and severe disease based on the Truelove-Witts criteria were considered to indicate active UC. All IBD patients had a total colonoscopy assessment and endoscopic findings were recorded according accepted endoscopic severity scores for UC and CD. In addition Red Cell Distribution Width (RDW), hemoglobin (HB), serum C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), serum albumin and platelet counts were measured. Results: Among the 94 patients included in the study, 48(51.1%) patients were classified to be in remission and 46(48.9%) patients were in relapse. Significant increases in RDW, CRP, ESR and platelet count with concomitant decrease in HB and serum albumin levels were ob-served in all groups compared to the control group (p < 0.0001 for all correlations except for albumin p=0.004). We also observed a significant difference in the above markers in the ac- ive disease periods of both CD and UC groups compared to the remission state (p

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More